Cargando…
Targeting Myeloid-Derived Suppressor Cell Trafficking as a Novel Immunotherapeutic Approach in Microsatellite Stable Colorectal Cancer
SIMPLE SUMMARY: Microsatellite stable colorectal cancer represents the majority of patients who have been diagnosed with colorectal cancer, and it is inherently resistant to currently available immunotherapy. After standard-of-care chemotherapy, patients have very limited remaining treatment options...
Autor principal: | Johnson, Benny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670242/ https://www.ncbi.nlm.nih.gov/pubmed/38001744 http://dx.doi.org/10.3390/cancers15225484 |
Ejemplares similares
-
Molecular characteristics of microsatellite stable early-onset colorectal cancer as predictors of prognosis and immunotherapeutic response
por: Lu, Can, et al.
Publicado: (2023) -
Myeloid-Derived Suppressor Cells in Colorectal Cancer
por: Sieminska, Izabela, et al.
Publicado: (2020) -
Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022) -
Editorial: New therapeutic approaches in microsatellite stable colorectal cancer patients
por: Bartolini, Michela, et al.
Publicado: (2023) -
Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer
por: Thibaudin, Marion, et al.
Publicado: (2023)